Cargando…
Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
BACKGROUND: Fiducial markers and daily electronic portal imaging (EPI) can reduce the risk of geographic miss in prostate cancer radiotherapy. The purpose of this study was to estimate CTV to PTV margin requirements, without and with the use of this image guidance strategy. METHODS: 46 patients unde...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896366/ https://www.ncbi.nlm.nih.gov/pubmed/20537161 http://dx.doi.org/10.1186/1748-717X-5-52 |
_version_ | 1782183343563997184 |
---|---|
author | Skarsgard, David Cadman, Pat El-Gayed, Ali Pearcey, Robert Tai, Patricia Pervez, Nadeem Wu, Jackson |
author_facet | Skarsgard, David Cadman, Pat El-Gayed, Ali Pearcey, Robert Tai, Patricia Pervez, Nadeem Wu, Jackson |
author_sort | Skarsgard, David |
collection | PubMed |
description | BACKGROUND: Fiducial markers and daily electronic portal imaging (EPI) can reduce the risk of geographic miss in prostate cancer radiotherapy. The purpose of this study was to estimate CTV to PTV margin requirements, without and with the use of this image guidance strategy. METHODS: 46 patients underwent placement of 3 radio-opaque fiducial markers prior to prostate RT. Daily pre-treatment EPIs were taken, and isocenter placement errors were corrected if they were ≥ 3 mm along the left-right or superior-inferior axes, and/or ≥ 2 mm along the anterior-posterior axis. During-treatment EPIs were then obtained to estimate intra-fraction motion. RESULTS: Without image guidance, margins of 0.57 cm, 0.79 cm and 0.77 cm, along the left-right, superior-inferior and anterior-posterior axes respectively, are required to give 95% probability of complete CTV coverage each day. With the above image guidance strategy, these margins can be reduced to 0.36 cm, 0.37 cm and 0.37 cm respectively. Correction of all isocenter placement errors, regardless of size, would permit minimal additional reduction in margins. CONCLUSIONS: Image guidance, using implanted fiducial markers and daily EPI, permits the use of narrower PTV margins without compromising coverage of the target, in the radiotherapy of prostate cancer. |
format | Text |
id | pubmed-2896366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28963662010-07-03 Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers Skarsgard, David Cadman, Pat El-Gayed, Ali Pearcey, Robert Tai, Patricia Pervez, Nadeem Wu, Jackson Radiat Oncol Research BACKGROUND: Fiducial markers and daily electronic portal imaging (EPI) can reduce the risk of geographic miss in prostate cancer radiotherapy. The purpose of this study was to estimate CTV to PTV margin requirements, without and with the use of this image guidance strategy. METHODS: 46 patients underwent placement of 3 radio-opaque fiducial markers prior to prostate RT. Daily pre-treatment EPIs were taken, and isocenter placement errors were corrected if they were ≥ 3 mm along the left-right or superior-inferior axes, and/or ≥ 2 mm along the anterior-posterior axis. During-treatment EPIs were then obtained to estimate intra-fraction motion. RESULTS: Without image guidance, margins of 0.57 cm, 0.79 cm and 0.77 cm, along the left-right, superior-inferior and anterior-posterior axes respectively, are required to give 95% probability of complete CTV coverage each day. With the above image guidance strategy, these margins can be reduced to 0.36 cm, 0.37 cm and 0.37 cm respectively. Correction of all isocenter placement errors, regardless of size, would permit minimal additional reduction in margins. CONCLUSIONS: Image guidance, using implanted fiducial markers and daily EPI, permits the use of narrower PTV margins without compromising coverage of the target, in the radiotherapy of prostate cancer. BioMed Central 2010-06-10 /pmc/articles/PMC2896366/ /pubmed/20537161 http://dx.doi.org/10.1186/1748-717X-5-52 Text en Copyright ©2010 Skarsgard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Skarsgard, David Cadman, Pat El-Gayed, Ali Pearcey, Robert Tai, Patricia Pervez, Nadeem Wu, Jackson Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers |
title | Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers |
title_full | Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers |
title_fullStr | Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers |
title_full_unstemmed | Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers |
title_short | Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers |
title_sort | planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896366/ https://www.ncbi.nlm.nih.gov/pubmed/20537161 http://dx.doi.org/10.1186/1748-717X-5-52 |
work_keys_str_mv | AT skarsgarddavid planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers AT cadmanpat planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers AT elgayedali planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers AT pearceyrobert planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers AT taipatricia planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers AT perveznadeem planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers AT wujackson planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers |